本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nurix Therapeutics

25.10
-0.7100-2.75%
盤後25.100.00000.00%19:30 EDT
成交量:132.17萬
成交額:3,359.78萬
市值:25.95億
市盈率:-7.36
高:26.65
開:26.31
低:25.00
收:25.81
52周最高:28.23
52周最低:8.20
股本:1.03億
流通股本:9,504.52萬
量比:1.11
換手率:1.39%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
淨資產收益率:-80.30%
總資產收益率:-40.06%
市淨率:6.45
市盈率(LYR):-8.23

資料載入中...

2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/24

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/08

重要事件披露

Form 8-K - Current report
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

重要事件披露

Form 8-K - Current report
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/28

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/09

重要事件披露

Form 8-K - Current report
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities